Neuronetics Inc (FRA:NRC)
€ 1.875 -0.10 (-5.06%) Market Cap: 143.72 Mil Enterprise Value: 209.42 Mil PE Ratio: 0 PB Ratio: 12.46 GF Score: 59/100

Q4 2025 Neuronetics Inc Earnings Call Transcript

Mar 17, 2026 / 12:30PM GMT
Release Date Price: €1.33 (+14.63%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the Neuronetics reports fourth quarter 2025 financial and operating results. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to turn the conference over to Mark Klausner. Sir, please go ahead.

Mark Klausner
ICR Healthcare - Investor Contact

Good morning and thank you for joining us for the Neuronetics 4th quarter 2025 conference call.

Joining me on today's call are Neuronetics President and Chief Executive Officer, Keith Sullivan and Steve Fanspiel, Neuronetics Chief Financial Officer.

Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1,995, including statements related to our business strategy, financial and revenue guidance, the Green Brook integration, and other operational issues and metrics.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot